uniQure to Participate in Multiple Upcoming Industry Conferences in September
September 03 2020 - 6:05AM
uniQure N.V. (NASDAQ: QURE), a leading gene therapy company
advancing transformative therapies for patients with severe medical
needs, today announced that Matt Kapusta, chief executive officer
at uniQure, Maria Cantor, senior vice president of investor
relations and communications, and Chiara Russo, associate director
of investor relations and communications, will participate in the
following upcoming conferences in September:
- Citi’s 15th Annual BioPharma Virtual Conference,
September 9 – 10, 2020
- A fireside chat with research analyst Shawn Egan will take
place on Wednesday, September 9, 2020 from 9:50 – 10:35 a.m. ET.
The live webcast of the chat can be accessed through the link
displayed in the Investor section of the uniQure website. The
webcast replay will be available for at least 72 hours following
the live event.
- Members of uniQure’s management team will participate in
virtual one-on-one investor meetings throughout the day on
Wednesday, September 9th.
- Baird’s Virtual Global Healthcare Conference, September
9 – 10, 2020
- Members of uniQure’s management team will participate in
virtual one-on-one investor meetings in the afternoon on Wednesday,
September 9, 2020.
- Wells Fargo Global Healthcare Conference, September 9 –
10, 2020 (Virtual)
- A fireside chat with research analyst Jim Birchenough will
take place on Thursday, September 10, 2020 from 10:00 – 10:30 a.m.
ET. The live webcast of the chat can be accessed through the link
displayed in the Investor section of the uniQure website. The
webcast replay will be available for at least 72 hours following
the live event.
- Members of uniQure’s management team will participate in
virtual one-on-one investor meetings throughout the day on
Thursday, September 10th.
- H.C. Wainwright 22nd Annual Global Investment
Conference, September 14 – 15, 2020 (Virtual)
- A fireside chat with research analyst Debjit Chattopadhyay
will take place on Monday, September 14, 2020 from 9:30 – 9:50 a.m.
ET. The live webcast of the corporate update can be accessed
through the link displayed in the Investor section of the uniQure
website. The webcast replay will be available for at least 72 hours
following the live event.
- Members of uniQure’s management team will participate in
virtual one-on-one investor meetings during the morning of Monday,
September 14, 2020.
- Cantor Fitzgerald Virtual Global Healthcare Conference,
September 15 – 17, 2020
- A fireside chat with analyst Eliana Merle will take place on
Wednesday, September 16, 2020 from 9:30 – 9:50 a.m. ET. The
live webcast of the corporate update can be accessed through the
link displayed in the Investor section of the uniQure website. The
webcast replay will be available for at least 72 hours following
the live event.
- Members of uniQure’s management team will participate in
virtual one-on-one investor meetings throughout the day on
Wednesday, September 16, 2020.
- Barclays Boston Biotech Bus Trip, September 23 – 25,
2020 (Virtual)
- An interactive group meeting with investors, moderated by
research analyst Gena Wang will take place on Friday, September 25,
2020 from 2:15 – 3:15 p.m. ET.
About uniQure uniQure is
delivering on the promise of gene therapy – single treatments with
potentially curative results. We are leveraging our modular and
validated technology platform to rapidly advance a pipeline of
proprietary gene therapies to treat patients with hemophilia B,
Huntington's disease, Fabry disease, spinocerebellar ataxia Type 3
and other diseases. www.uniQure.com
uniQure Contacts: |
|
FOR INVESTORS: |
|
|
|
FOR MEDIA: |
|
|
|
|
|
Maria E. Cantor |
|
Chiara Russo |
|
Tom Malone |
Direct: 339-970-7536 |
|
Direct: 617-306-9137 |
|
Direct: 339-970-7558 |
mcantor@uniQure.com |
|
c.russo@uniQure.com |
|
t.malone@uniQure.com |
uniQure NV (NASDAQ:QURE)
Historical Stock Chart
From Sep 2024 to Oct 2024
uniQure NV (NASDAQ:QURE)
Historical Stock Chart
From Oct 2023 to Oct 2024